Private equity firm JLL Patheon Holdings went ahead yesterday with its unsolicited $2-per-share bid for Patheon that would take the company into private ownership.
Contract research organisation PharmaNet Development Group has found a buyer just a few weeks after saying it was considering placing itself on the block.
Finnish chemicals group Kemira has agreed to sell off its fine
chemicals business to a private equity firm, exiting from what it
sees as a non-core sector, reports Phil Taylor.
Germany's MG technologies has agreed to sell the bulk of its
Dynamit Nobel chemicals division, sealing the fate of a company
that has been on the block since last November, writes Phil
Taylor.
The addition of HarbourVest Partner to Israeli life sciences
venture capital fund Vitalife prompted the fund to announce on
Monday the closing of its first fund, worth €46 million.